Acrivon Therapeutics, Inc. · NASDAQ:ACRV

Peterson Katharine received 14,227 Acrivon Therapeutics, Inc. shares as an award (Form 4)

Traded May 18, 2026 · Filed May 20, 2026

On May 18, 2026, Peterson Katharine (Chief Accounting Officer) received 14,227 Acrivon Therapeutics, Inc. shares as an award, leaving 18,134 shares. Filed May 20, 2026 (Form 4).

Awarded
14,227 shares
Holding after
18,134 shares
Trading plan
No
Role
Chief Accounting Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 18, 2026Common StockAward14,22718,134Direct

Source

View original at SEC

Related